CORE EARNINGS PER SHARE: Core earnings per share are expected to rise to $2.07 from $1.45 the year prior, according to the same consensus. AstraZeneca's stock is up 7.9% since the start of 2024.

Shares in the media company surged to their highest in near six years as its quarterly results were bolstered by higher US ...

PepsiCo Inc. (NASDAQ:PEP) reported its fourth-quarter 2024 earnings with an earnings per share (EPS) of $1.96, slightly above ...

Shares of GE Aerospace gained 22% in January, according to data provided by S&P Global Market Intelligence, after the company ...

Shares of Merck are sliding in early trading after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales ...

Q1 2025 Earnings Conference Call February 4, 2025 10:00 AM ET. Company Participants. Jon Poldan - Vice President, Treasurer & Investor Relation ...

Palantir stock is soaring Tuesday after the AI software giant beat Q4 expectations and gave a strong outlook for the year ...

Merck (MRK) stock was mangled today after the pharmaceutical and vaccine company released its guidance for 2025. The company expects adjusted ...

PayPal (PYPL) stock plunged as the company reported a decline in payment transactions, despite earnings beating on both the ...

The software company has been on a record run, surging 340% in 2024 as its AI platform gained traction amid ongoing investor ...

Sales slid 17% to $661.6 million, short of the average Wall Street target of $679.8 million, as per FactSet. Sales at its electrical unit slid 22% to $465.4 million. For the year ending in September, ...

The results cap off a critical year for Pfizer, which has been slashing costs as it recovers from the rapid decline of its ...